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Summary
 
The stimulatory and inhibitory pathways initiated by engagement of stimulatory receptors such
as the B cell receptor for antigen (BCR) and inhibitory receptors such as Fc
 
g
 
 receptors of the
IIB1 type (Fc
 
g
 
RIIB1) intersect in ways that are poorly understood at the molecular level. Be-
cause the tyrosine kinase Csk is a potential negative regulator of lymphocyte activation, we ex-
amined the effects of BCR and Fc
 
g
 
RIIB1 engagement on the binding of Csk to phosphoty-
rosine-containing proteins. Stimulation of a B lymphoma cell line, A20, with intact anti-IgG
antibody induced a direct, SH2-mediated association between Csk and a 62-kD phosphoty-
rosine-containing protein that was identified as RasGTPase-activating protein–associated p62
(GAP-A.p62). In contrast, stimulation of A20 cells with anti-IgG F(ab
 
9
 
)
 
2
 
 resulted in little in-
crease in the association of Csk with GAP-A.p62. The effect of Fc
 
g
 
RIIB1 engagement on this
association was abolished by blockade of Fc
 
g
 
RIIB1 with the monoclonal antibody 2.4G2. Fur-
thermore, the increased association between Csk and GAP-A.p62 seen upon stimulation with
intact anti-Ig was abrogated in the Fc
 
g
 
RIIB1-deficient cell line IIA1.6 and recovered when
Fc
 
g
 
RIIB1 expression was restored by transfection. The differential effects of BCR and BCR-
Fc
 
g
 
RIIB1–mediated signaling on the phosphorylation of GAP-A.p62 and its association with
Csk suggest that docking of Csk to GAP-A.p62 may function in the negative regulation of an-
tigen receptor–mediated signals in B cells.
 
A
 
t the cellular level, the quality and magnitude of im-
mune responses are determined by the summation of
positive and negative signals. In B lymphocytes, for exam-
ple, the relative levels of stimulatory and inhibitory signal-
ing determine the amount and duration of antibody pro-
duction and the type of antibody produced. Mediating
such signals at the B cell surface are stimulatory receptors
such as the BCR and inhibitory receptors such as Fc
 
g
 
 re-
ceptors of the IIB1 type (Fc
 
g
 
RIIB1). Although aspects of
proximal signaling through the BCR and Fc
 
g
 
RIIB1 have
been defined, the intersection of stimulatory and inhibitory
pathways initiated by engagement of these receptors is
poorly understood at the biochemical level.
The BCR consists of membrane-bound immunoglobu-
lin (sIg) and associated Ig-
 
a
 
 and Ig-
 
b
 
 heterodimers. En-
gagement of the B cell receptor for antigen (BCR)
 
1
 
 ini-
tiates a cascade of tyrosine phosphorylation, resulting in the
activation of Ras- and phospholipase-dependent signal trans-
duction pathways and culminating in proliferative and dif-
ferentiative responses (reviewed in reference 1). BCR stim-
ulation induces immediate activation of the Src-related
tyrosine kinases Lyn, Fyn, and Blk, followed within min-
utes by activation of the non–Src-related tyrosine kinases
Btk and Syk (2). Genetic evidence clearly implicates Syk
(3, 4) and Btk (5, 6) as essential for normal B cell prolifera-
tion in response to BCR engagement; no single Src-related
kinase, however, is essential for BCR signaling in the
mouse (7–9). In contrast, ablation of Lyn in the chicken B
cell line DT40, which expresses a restricted repertoire of
Src-related kinases, abrogates signaling through the BCR
(10), supporting the view that Src-related kinases play es-
sential, if redundant, roles in B cell activation.
Although the mechanisms that underlie negative regula-
tion of BCR signaling are incompletely understood, several
consequences of BCR stimulation, including phosphoino-
sitide hydrolysis, increased free intracellular calcium, cellu-
lar proliferation, and immunoglobulin secretion, can be
inhibited by engagement of Fc
 
g
 
RIIB1 (11, 12). As a con-
sequence of this inhibitory effect, intact anti-Ig antibodies,
which engage both the BCR and Fc
 
g
 
RIIB1, are relatively
 
1
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ineffective polyclonal B cell activators in comparison to
F(ab
 
9
 
)
 
2
 
 fragments, which cannot engage Fc
 
g
 
RIIB1 (13,
14). A conserved 13–amino acid motif in the cytoplasmic
portion of Fc
 
g
 
RIIB1 (the immunoreceptor tyrosine-based
inhibitory motif) is required for inhibition (15). The im-
munoreceptor tyrosine-based inhibitory motif of Fc
 
g
 
RIIB1
represents a docking site for the SH2 domains of at least
two proteins, the tyrosine phosphatase SHP1 (16) and the
inositide phosphatase SHIP (17), either of which may me-
diate inhibitory effects.
The COOH-terminal Src kinase (Csk) represents an-
other potential negative regulator of lymphocyte activa-
tion. Csk specifically phosphorylates a conserved tyrosine
residue near the COOH terminus of Src and related ki-
nases, thereby inhibiting catalytic activity (18). Correspond-
ingly, cells derived from Csk-deficient mouse embryos,
which die at mid-gestation, exhibit increased activity of Src
and related kinases (19, 20). In response to extracellular sig-
nals, the activity of Csk is known to be modulated by
changes in its intracellular localization (21). In T lympho-
cytes, overexpression of Csk suppresses phosphorylation of
tyrosine kinase substrates and lymphokine secretion in re-
sponse to antigenic stimulation, possibly by inhibition of
the Src-related kinases Lck and Fyn, which have been im-
plicated as mediators of signaling through the T cell recep-
tor (22). Deletion of the SH2 or SH3 domains of Csk abro-
gates the inhibition of antigen receptor signaling in T cells
(23); this result is consistent with the ability of similar mu-
tations to suppress Csk-induced inactivation of Src in fibro-
blastoid cells (24). The effect of an SH2-inactivating muta-
tion could be corrected by targeting Csk to the plasma
membrane, suggesting that with respect to inhibition of an-
tigen receptor signaling, the SH2 domain of Csk provides
an essential localization function (21, 23). One specific
means of localization was suggested by the recent observa-
tion (25) that in cells expressing activated forms of Src, the
SH2 domain of Csk interacts with the Ras GTPase-activat-
ing protein (GAP)-associated p62 protein (GAP-A.p62); this
complex is found in subcellular membrane or cytoskeletal
fractions. Thus, GAP.A-p62 may represent a docking pro-
tein for Csk, RasGAP, and possibly other ligands.
Csk, therefore, may be situated at a point of intersection
between positive and negative signaling in lymphocytes.
Because Fc
 
g
 
RIIB1 is known to inhibit B cell stimulation
through the BCR, we wished to determine whether en-
gagement of Fc
 
g
 
RIIB1 leads to events that alter Csk’s asso-
ciation with other proteins; such changes could modify
stimulatory signaling through the BCR. To test this hy-
pothesis, we examined the effects of BCR and Fc
 
g
 
RIIB1
engagement on the binding of Csk to phosphotyrosine-
containing proteins in a B lymphoma cell line, A20. Stimu-
lation of A20 cells with intact anti-IgG antibody induced a
direct, SH2-mediated association between Csk and a 62-
kD phosphotyrosine-containing protein which was identi-
fied as GAP-A.p62. In contrast, stimulation of A20 cells
with anti-IgG F(ab
 
9
 
)
 
2
 
 resulted in less of an increase in asso-
ciation between Csk and GAP-A.p62. Treatment of A20
cells with the monoclonal antibody 2.4G2, which blocks
Fc
 
g
 
RIIB, abolished the ability of intact anti-IgG antibodies
to induce association of Csk with GAP-A.p62. Further-
more, the differential effect of intact anti-IgG and F(ab
 
9
 
)
 
2
 
on association of Csk with GAP-A.p62 was abolished in
the Fc
 
g
 
RIIB-deficient, A20-derived mutant cell line, IIA1.6,
and was restored in IIA1.6 cells transfected with wild-type
Fc
 
g
 
RIIB1. Taken together, these observations indicate that
BCR- and Fc
 
g
 
RIIB1-mediated signaling have differential
effects on the phosphorylation of GAP-A.p62 and its asso-
ciation with Csk. These findings suggest that Csk functions
in the negative regulation of antigen receptor-mediated
signals in B cells.
 
Materials and Methods
 
Cell Lines.
 
A20 cells were obtained from the American Type
Culture Collection (Rockville, MD). Cells were cultured in
RPMI 1640 media (GIBCO BRL, Gaithersburg, MD) supple-
mented with 5% fetal bovine serum and 50 
 
m
 
mol 2-mercaptoeth-
anol. IIA1.6 cells were a gift from Charles Janeway (Yale Univer-
sity, New Haven, CT) and John Cambier (National Jewish
Center, Denver, CO). They were cultured in IMDM supple-
mented with 5% fetal bovine serum. IIA1.6 cells transfected with
Fc
 
g
 
IIB1 (CT314; a gift from J. Cambier) were grown in media
supplemented with 0.5 mg/ml G418. All cells were grown in 5%
CO
 
2
 
 at 37
 
8
 
C.
 
Antibodies.
 
The phosphotyrosine-specific mAb PY20, an anti-
Csk mAb, and antibodies against p125
 
Fak
 
 were purchased from
Transduction Laboratories (Lexington, KY). The antiphosphoty-
rosine mAb 4G10 was purchased from Upstate Biotechnology
Inc. (Lake Placid, NY). Affinity-purified, polyclonal, agarose-conju-
gated and unconjugated rabbit antibodies against Csk and mono-
clonal, agarose-conjugated antibodies against RasGAP and Csk
were purchased from Santa Cruz (Santa Cruz, CA). Polyclonal
rabbit antibodies against GAP were a gift from Dr. Tony Pawson
(Mount Sinai Hospital, Toronto, Canada); those against Sam68
were provided by Andrey Shaw (University of Washington, St.
Louis, MO). mAb 2C4 against GAP-A.p62 was provided by Rich-
ard Roth (Stanford University, Stanford, CA). Antibodies against
paxillin were purchased from Zymed Labs., Inc. (S. San Fran-
cisco, CA). mAb 2.4G2 was purchased from PharMingen (San
Diego, CA).
 
Construction and Isolation of Glutathione S Transferase Fusion Pro-
teins.
 
A cDNA clone encoding Csk was provided by Akira Ima-
moto (Fred Hutchinson Cancer Research Center, Seattle, WA).
DNA fragments encoding SH2 (amino acids 77–180), SH3
(amino acids 14–68), and SH3/2 (amino acids 14–180) of Csk
were amplified by the PCR. These fragments were cloned be-
tween the BamHI and EcoRI restriction sites of the 
 
Escherichia coli
 
expression vector pGEX-2T (Pharmacia, Piscataway, NJ) to pro-
duce the plasmids pGEX-2T-CskSH2, pGEX-2T-CskSH3, and
pGEX-2T-CskSH3/2. Cassettes for expression of Csk mutants
R107K and S109C were generated by PCR using 3
 
9
 
 Csk antisense
primers specifying the mutations of interest (R107K: 5
 
9
 
-GTT
CCT CGT GAA GGA AAG CAC C-3
 
9
 
; S109C: 5
 
9
 
-CGT GCG
GGA ATG CAC CAA CTA CCC-3
 
9
 
). The resulting fragments
were cloned into pGEX-2T as above. All constructions were ver-
ified by nucleotide sequencing.
Plasmids encoding glutathione S transferase (GST) fusion pro-
teins were introduced into 
 
E. coli 
 
strain DH5
 
a
 
. Transfectants
were cultured overnight at 37
 
8
 
C in Luria broth supplemented
with ampicillin at 50 
 
m
 
g/ml. Overnight cultures were diluted 1:10 
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into fresh medium supplemented with ampicillin and grown at
37
 
8
 
C to an OD
 
595
 
 of 0.6–1.0; expression of fusion proteins was
then induced by addition of isopropyl-1-thio-
 
b
 
-
 
d
 
-galactopyra-
noside to 0.1 mM. After 4 h, bacteria were pelleted and resus-
pended in ice-cold PBS supplemented with protease inhibitors
and Triton X-100 to a final concentration of 1%. The mixtures
were incubated for 20–30 min on ice and lysis was completed by
sonication (4 cycles of 10 pulses each with a Branson [Danbury,
CT] microtip sonifier at output 2-3, duty cycle 50%). Lysates
were clarified by centrifugation at 10,000 
 
g 
 
for 15 min at 4
 
8
 
C. Su-
pernatants were incubated with 500 
 
m
 
l of a 50% slurry of glu-
tathione–agarose beads and incubated for 15 min at room tem-
perature. Beads were washed five times with PBS. The amount of
bound protein was estimated by SDS-PAGE and Commassie
staining. To prepare affinity matrices for use in binding assays, the
amount of bacterial lysate used in each adsorption was adjusted to
produce beads of similar substituent density. Beads were stored
on ice as a 50% slurry in PBS supplemented with 1 mM PMSF,
10% glycerol, and were used within one week of preparation.
 
Cell Stimulation.
 
Before stimulation, cells were washed in
PBS, resuspended in serum-free RPMI 1640 medium, and incu-
bated at 37
 
8
 
C for 20 min. Cells (10
 
8
 
/ml) were stimulated with
F(ab
 
9
 
)
 
2
 
 (30 
 
m
 
g/ml) or intact (50 
 
m
 
g/ml) anti-IgG antibodies
(Jackson ImmunoResearch Labs., Inc., West Grove, PA) in se-
rum-free RPMI for 1 min at 37
 
8
 
C unless otherwise indicated. In
2.4G2 blockade experiments, cells were incubated with medium
or 50 
 
m
 
g/ml 2.4G2 antibodies for 15 min at room temperature
before stimulation with anti-IgG antibodies.
 
Immunoprecipitation.
 
Pellets of unstimulated or stimulated cells
were lysed in 1% Triton lysis buffer (150 mM NaCl, 20 mM
Tris-HCl [pH 7.6], 10 
 
m
 
g/ml of aprotinin, 1 mM EDTA, 1 mM
sodium orthovanadate, and 1 mM phenylmethylsulfonyl fluoride,
10% glycerol, and 1% Triton X-100). Lysates were cleared by
centrifugation at 13,000 
 
g
 
 for 15 min. Cell lysates were precleared
with normal rabbit Ig or normal mouse Ig and Sepharose A
(Repligen Corp., Cambridge, MA), or normal rabbit serum co-
valently coupled to Sepharose (Sigma Chemical Co., St. Louis,
MO). Proteins of interest were precipitated at 4
 
8
 
C using affinity
purified, agarose-conjugated antibodies (10 
 
m
 
g) for 1 h. Immuno-
complexes were washed five times in lysis buffer.
 
In Vitro Binding Assays.
 
Cell lysates were incubated with 3–10
 
m
 
g of GST fusion proteins at 4
 
8
 
C for 2–4 h and washed four
times with lysis buffer. Some samples were boiled in lysis buffer
supplemented with 1% SDS for 5 min, diluted 10-fold in 1% Tri-
ton lysis buffer, and incubated with GST fusion proteins as indi-
cated above. For phospho–amino acid competition, twofold serial
dilutions of cell lysates were incubated with GST-CskSH2 beads
in the presence of 50 mM 
 
l
 
-phosphotyrosine or 25 mM each of
 
l
 
-phosphoserine and 
 
l
 
-phosphothreonine.
 
Immunoblot Assays.
 
Proteins were eluted from beads by boil-
ing in SDS sample buffer, separated by SDS–polyacrylamide gel
electrophoresis, and transferred to nitrocellulose. Filters were
blocked with 5% nonfat dry milk in PBS, 0.1% Tween 20 for 1 h,
and incubated with primary antibodies for 1–5 h at room temper-
ature. Antibodies were used at dilutions recommended by suppliers.
Horseradish peroxidase–conjugated goat anti–mouse or anti–rab-
bit antibodies were used to detect primary antibodies and visualized
by an enhanced chemiluminiscence assay (ECL; Amersham
Corp., Arlington Heights, IL).
 
In Vitro Kinase Assay and Phosphopeptide Mapping.
 
After precipi-
tation as described above, complexes were washed three times in
lysis buffer, two times in kinase buffer (20 mM Tris-HCl [pH
7.6], 10 mM MgCl
 
2
 
, 5 mM MnCl
 
2
 
, 1 mM 2-mercaptoethanol),
and incubated in 100 
 
m
 
l of kinase buffer supplemented with 10
 
m
 
Ci of [
 
g
 
-
 
32
 
P]ATP for 30 min at room temperature. After wash-
ing, labeled proteins were separated by SDS–polyacrylamide gel
electrophoresis. Phosphopeptide mapping was performed as de-
scribed previously (26). In brief, 
 
32
 
P-labeled 62-kD bands from
Csk and RasGAP immunoprecipitates were digested without
previous dilution by placing gel slices containing these bands in
the sample wells of a second, 15% SDS polyacrylamide gel contain-
ing a 5.5-cm stacking layer and then overlaying each slice with 10
 
m
 
l V-8 protease solution (20 
 
m
 
g/ml). Digestion was carried out in
the stacking gel during subsequent electrophoresis at 20 mA. Af-
ter the bromophenol blue dye reached the bottom of the stacking
gel, current was turned off for 30 min, after which time electro-
phoresis was resumed.
 
Results
 
Association of Csk with Phosphotyrosine-containing Proteins
from A20 B Cells Stimulated with Intact Anti-IgG or F(ab
 
9
 
)
 
2
 
.
 
As a first step toward identifying proteins associated with
Csk under conditions of BCR and Fc
 
g
 
RIIB stimulation,
A20 cells were incubated with intact anti-IgG antibody or
with F(ab
 
9
 
)
 
2
 
 fragments of similar specificity, and phospho-
tyrosine-containing proteins were detected in anti-Csk im-
munoprecipitates by immunoblotting. Several phosphoty-
rosine-containing species, including proteins of 62, 97, and
125 kD (p62, p97, and p125, respectively), were observed
to immunoprecipitate with Csk (Fig. 1). The amount of
p62 detectable in Csk immunoprecipitates by antiphospho-
tyrosine immunoblotting increased significantly after stim-
ulation, indicating an elevation in phosphotyrosine con-
tent, association with Csk, or both. However, the increase
in antiphosphotyrosine reactivity of p62 was substantially
greater after stimulation with intact antibodies than with
F(ab
 
9
 
)
 
2. The antiphosphotyrosine signals associated with
p97 and p125, in contrast, showed relatively little change
after stimulation with anti-IgG antibodies.
The SH2 Domain of Csk Binds p62 Directly through a Spe-
cific, Phosphotyrosine-dependent Interaction. To identify the
region(s) of Csk that bind p62, the SH2 and SH3 domains
Figure 1. Stimulation-depen-
dent association of p62 and Csk
in vivo. A20 cells were unstimu-
lated (lanes 1–3), stimulated with
intact anti–mouse IgG (lanes 4–6),
or stimulated with F(ab9)2 (lanes
7–9). Precleared cell lysates were
incubated with normal rabbit
immunoglobulin (lanes 2, 5, and
8) or affinity-purified rabbit anti-
bodies against Csk (lanes 3, 6,
and 9). One-tenth of the total
amount of lysate used in each
experiment was fractionated in
parallel (lanes 1, 4, and 7). Im-
munoprecipitated proteins were
fractionated on a 10% SDS–
polyacrylamide gel, were trans-
ferred to nitrocellulose, and immunoblotted with an antiphosphotyrosine
antibody (PY20). The membrane was stripped and Csk was detected by
immunoblotting.262 Csk-p62 Association after B Cell Receptor–FcgRIIB1 Engagement
of Csk were fused individually or in combination to GST.
The resulting reagents (GST-CskSH2, GST-CskSH3, and
GST-SH3/2) were assayed for binding to phosphotyrosine-
containing proteins from lysates of unstimulated A20 cells
or A20 cells that had been stimulated with intact anti-IgG.
After stimulation, p62 was the most prominent of the phos-
photyrosine-containing proteins retained by GST-CskSH2
(Fig. 2 A). Detection of p62 reached a maximum within 2
min of stimulation, but remained detectable at 60 min after
stimulation (data not shown). The p62 antiphosphotyrosine
signal associated with GST-CskSH3/2 was greater than that
associated with GST-CskSH2 alone, consistent with previ-
ous observations indicating that flanking SH3 domains in-
fluence the affinity of SH2 domains for phosphopeptides.
Neither GST-CskSH3 nor GST alone exhibited binding to
phosphotyrosine-containing proteins from A20 cells. In
separate experiments in which cells were stimulated with
an anti-IgG F(ab9)2 fragment, p62 was also present, but the
antiphosphotyrosine signal associated with p62 was weak in
comparison to that observed after stimulation with intact
antibodies. As was observed after stimulation with intact
anti-IgG, GST-CskSH3 and GST alone failed to retain ty-
rosine phosphorylated proteins from A20 cells stimulated
with F(ab9)2 (data not shown).
SH2 domains are able to recognize extended phospho-
peptide sequences that persist after disruption of protein
ternary structure by denaturation. This property allowed us
to determine whether the interaction between the Csk
SH2 domain and p62 was direct. Lysates of unstimulated
A20 cells or A20 cells stimulated with intact anti-IgG were
denatured by boiling in 1% SDS, diluted 10-fold in lysis
buffer, and assayed for binding to GST-CskSH3/SH2 (Fig.
2 B) or GST-CskSH2 (data not shown). Both fusion pro-
teins retained p62 even after denaturation of A20 proteins
in SDS, suggesting that their interaction with p62 is direct.
Notably, p62 was the only protein from stimulated cells
observed to bind to the Csk SH2 domain after SDS dena-
turation. Similar results were obtained after stimulation of A20
cells with an anti-IgG F(ab9)2 fragment (data not shown).
Two approaches were taken to examine the phosphoty-
rosine dependence of the interaction between p62 and the
Csk SH2 domain. When a stimulated A20 cell lysate was
serially diluted and incubated with GST-CskSH2 in the
presence of free phosphotyrosine, retention of p62 was re-
duced; this reduction was specific, as an equimolar mixture
of phosphoserine and phosphothreonine had no effect (Fig.
2 C). The specificity of competition by free phosphoty-
rosine suggests that binding of p62 to the Csk SH2 domain
is phosphotyrosine dependent. The conserved FLVRES
motif (amino acid residues 104–109 of Csk) comprises part
of the phosphotyrosine binding site of SH2 domains, and
mutations within this motif abolish or greatly reduce bind-
ing to phosphotyrosine-containing proteins (27–29). To
test the specificity of p62 binding to the Csk SH2 domain,
R107K and S109C mutations were introduced. A lysate of
A20 cells, stimulated with intact anti-IgG, was serially di-
luted and assayed for binding to wild-type and mutant GST-
Figure 2. Association of Csk with p62 is mediated by a direct, phos-
photyrosine-dependent interaction with the Csk SH2 domain. (A) A20
cells were unstimulated or stimulated for 1, 2, or 10 min with intact anti–
mouse IgG. Cells were lysed, split into four samples, and soluble proteins
were assayed for binding to GST-CskSH2 (lanes 1–4), GST-CskSH3
(lanes 5–8), GST-CskSH3/SH2 (lanes 9–12), or GST (lanes 13–16). (B)
Cells were unstimulated or stimulated for 1 min with intact anti–mouse
IgG. SDS was added to a final concentration of 1%. Samples were either
boiled or left on ice, and then diluted 10-fold in lysis buffer. Lysates were
incubated with GST-CskSH3/2 (lanes 3–6) or GST (lanes 1 and 2). (C)
Twofold serially diluted lysates of cells stimulated with intact anti–mouse
IgG were incubated with GST-CskSH2 in the absence (lanes 1–5) or
presence of 25 mM each phosphoserine (pSer) and phosphothreonine
(pThr) (lanes 6–10), or in the presence of 50 mM phosphotyrosine (pTyr)
(lanes 11–15). (D) Cells were stimulated for 1 min with intact anti–mouse
IgG. Lysates were diluted serially twofold and incubated with equal
amounts of GST-CskSH2 (lanes 1–4), GST-CskSH2 R107K (lanes 5–8),
or GST-CskSH2 S109C (lanes 9–12). Proteins bound to GST fusions
were precipitated as described in Materials and Methods, fractionated by
SDS–polyacrylamide gel electrophoresis, and detected by immunoblot-
ting with an antiphosphotyrosine antibody (4.G10).263 Vuica et al.
CskSH2 domains. Although the S109C mutation abolished
binding of the Csk SH2 domain to p62, the R107K muta-
tion had little effect (Fig. 2 D).
Csk-associated p62 also Associates with RasGAP. The abil-
ity of the R107K mutant to bind p62 was unexpected and
reminiscent of the binding of GAP-A.p62 to the Csk SH2
domain, which is known to persist after mutation of R107
(25). To test whether the 62-kD species might represent
GAP-A.p62, A20 cells were stimulated with intact anti-
IgG; tyrosine phosphorylated co-migrating 62-kD proteins
were detected in RasGAP, Csk, and Csk SH2 precipitates
(Fig. 3 A). Next, A20 cells were stimulated with intact
anti-IgG and lysates were immunodepleted using antibod-
ies specific for Csk, RasGAP, the 62-kD phosphoprotein
recognized by mAb 2C4 (30), or Sam68, a protein initially
identified as related to RasGAP-associated p62 (31). Im-
munodepleted or undepleted lysates were then assayed for
protein binding to GST (data not shown) or GST-CskSH2.
The amount of tyrosine phosphorylated p62 recovered
from GST-CskSH2 after immunodepletion of RasGAP
was reduced significantly in comparison to a control im-
munodepletion with nonimmune antibody (Fig. 3 B). The
recovery of p62 was also reduced after immunodepletion of
Csk, as expected. In contrast, immunodepletion of Sam68
had no effect on the recovery of p62 from the GST-CskSH2
eluate. Because the 2C4 antibody does not detect its ligand
on immunoblot, we were not able to estimate how much
of the 2C4-binding p62 species was depleted in this exper-
iment. These results indicate that p62 interacts with Ras-
GAP in A20 cell lysates, and are consistent with the inter-
pretation that the Csk-associated p62 is related to or identical
to GAP-A.p62.
We used the ability of SH2 domains to recognize ex-
tended phosphopeptide sequences to determine whether
the Csk SH2 domain could bind directly to GAP-A.p62.
We were able to show that the Csk SH2 domain can rec-
ognize p62 from denatured RasGAP immunocomplexes,
further supporting the interpretation that GAP-A.p62 rep-
resents the same species as Csk-associated p62 (Fig. 3 C).
To demonstrate this more directly, we generated 32P-labeled
RasGAP- and Csk-associated p62 in immunoprecipitates
by an in vitro kinase assay, and compared partial V-8 pro-
tease digestion products by SDS–gel electrophoresis (Fig. 3
D). The proteins yielded similar distributions of phospho-
peptides, indicating that these two species are related pro-
teins.
Engagement of FcgRIIB1 Induces an Increase in the Associa-
tion of Tyrosine Phosphorylated p62 with Csk. Intact anti-IgG
induced a greater increase in the antiphosphotyrosine reac-
tivity of Csk-associated p62 than stimulation with F(ab9)2.
We considered whether engagement of FcgRIIB1 engage-
ment, as would occur upon stimulation with intact anti-
body, could account for this difference. To test this, we
stimulated A20 cells in the presence or absence of the
2.4G2 mAb, which blocks signaling through the FcgRIIB
receptor (32). Treatment of A20 cells with 2.4G2 alone in-
Figure 3. The 62-kD protein
bound to Csk is associated with
RasGAP. (A) Lysates of A20
cells stimulated with intact anti-
IgG were incubated with aga-
rose-conjugated normal mouse
antibodies (lane 1), mAbs against
RasGAP (lane 2), normal rabbit
antibodies (lane 3), or affinity-
purified antibodies against Csk
(lane 4). Alternatively, lysates
were incubated with GST (lane
5) or GST-CskSH2 (lane 6). (B)
Lysates were immunodepleted
with normal rabbit serum (lane
1), antibodies against Csk (lane
2), RasGAP (lane 3), Sam68
(lane  4), normal mouse immu-
noglobulin (lane 5) or p62
(Transduction Laboratories; lane
6, 2C4; lane 7). Depleted lysates
were then precipitated with
GST-CskSH2 (lanes 1–6). (C)
RasGAP was precipitated as de-
scribed above (lanes 2–4). The
sample was boiled in lysis buffer
containing 1% SDS. One-third
was reserved for analysis of the RasGAP immunoprecipitate. The remaining two-thirds of the sample was diluted 10-fold in lysis buffer, split into two al-
iquots, and incubated either with GST (lane 3) or GST-CskSH2 (lane 4). A control immunoprecipitation was performed with normal mouse immuno-
globulin (lane 1). All precipitates (A–C) were separated by 9% SDS-PAGE and analyzed by immunoblotting with antiphosphotyrosine antibodies. Mem-
branes were stripped and reprobed either with mAbs against Csk or rabbit serum against RasGAP. (D) RasGAP and Csk immunoprecipitates were
subjected to an in vitro kinase assay; 32P-labeled p62 was isolated from each precipitate by gel electrophoresis, excised, and analyzed by partial V-8 pro-
teolysis as described in Materials and Methods. Phosphopeptides were visualized by autoradiography.264 Csk-p62 Association after B Cell Receptor–FcgRIIB1 Engagement
duced an increase in SH2-associated, tyrosine-phosphory-
lated p62 similar to that observed upon stimulation by
F(ab9)2. Strikingly, in the presence of 2.4G2, the amount of
tyrosine phosphorylated p62 that bound GST-CskSH2 in
response to stimulation with intact anti-IgG was reduced to
the level observed after stimulation with F(ab9)2 (Fig. 4 A).
To confirm the involvement of FcgRIIB1 in the re-
sponse of p62 to stimulation with intact antibody we used
two cell lines derived from A20: IIA1.6, which lacks Fcg-
RIIB, and CT314, a IIA1.6 derivative in which expression
of wild-type FcgRIIB1 has been restored by transfection
(33). In agreement with results of the FcgRIIB1 blockade
experiment, IIA1.6 cells failed to exhibit a difference in the
recovery of tyrosine phosphorylated p62 from GST-CskSH2
beads after stimulation with F(ab9)2 relative to stimulation
with intact anti-IgG (Fig. 4 B, middle). This difference was
reestablished in IIA1.6 cells transfected with FcgRIIB1
(Fig. 4 B, bottom). Taken together, these results strongly
suggest that the observed difference in the association of ty-
rosine-phosphorylated p62 with the Csk SH2 domain after
stimulation of A20 cells with intact anti-IgG or F(ab9)2 is
the result of differential phosphorylation of p62 after BCR
or FcgRIIB1 engagement.
Discussion
Although the ability of FcgRIIB1 to oppose stimulation
of B cell responses by engagement of the BCR is well doc-
umented, the mechanism by which FcgRIIB1 antagonizes
the BCR is incompletely understood. The participation of
Src-related kinases in BCR-mediated signaling and the
ability of Csk to suppress Src-related kinase activity in rest-
ing B cells suggested the possible participation of Csk in an-
tagonism of BCR signaling by FcgRIIB1. In response to
extracellular signals, the activity of Csk is known to be
modulated by changes in its intracellular localization (21,
23). Recruitment of Csk into a signaling pathway emanat-
ing from FcgRIIB1 would therefore be expected to in-
volve FcgRIIB1-induced changes in the association of Csk
with other proteins or in the phosphorylation state of pro-
teins known to interact with Csk. In this communication
we have demonstrated that signaling through FcgRIIB1
induces tyrosine phosphorylation of a 62-kD protein (p62)
that associates with the SH2 domain of Csk. In compari-
son, engagement of the BCR has relatively little effect on
phosphorylation of p62 or on the ability of p62 to bind
Csk. Thus, the effect of FcgRIIB1 engagement on p62 is
relatively specific.
By its association with RasGAP, the 62-kD, Csk-associ-
ated protein phosphorylated in response to FcgRIIB1 en-
gagement is likely to represent GAP-A.p62. This interpre-
tation is in agreement with the recent observation that Csk
is associated with GAP-A.p62 in murine fibroblasts stably
expressing v-Src or an activated c-Src mutant (24). A
cDNA previously reported to encode GAP-A.p62 has been
shown since to encode a distinct protein, Sam68, a major
Src substrate in mitotic cells (34, 35). Sam68 does not ap-
pear to represent the major phosphotyrosine-containing
protein associated with GAP (31). Although an antibody
against Sam68 detected small amounts of as yet unidentified
phosphotyrosine-containing proteins in CskSH2 precipi-
tates, antibodies against Sam68 were unable to precipitate
Csk from lysates of stimulated A20 B cells (data not shown).
In addition to GAP-A.p62, we were able to detect two
other phosphotyrosine-containing proteins, p125 and p97,
that associated with the Csk SH2 domain in vivo. Unlike
p62, the association of p125 and p97 with Csk SH2 did not
increase after stimulation of A20 cells through FcgRIIB1
or the BCR. The 125-kD protein was not reactive with
antibodies against p125Fak, nor was it immunoprecipitated
by antibodies against RasGAP. Although, under the condi-
tions described above, we observed little or no binding of
p125 to CskSH2 in vitro, some binding of p125 could be
observed when large amounts of A20 cell lysates were used
Figure 4. Blockade or absence
of FcgRIIB1 abolishes the in-
crease in Csk-associated p62 after
treatment with intact antibodies.
(A) A20 cells were unstimulated
(lanes 1, 4, 7, and 10), stimulated
by F(ab9)2 (lanes 2, 5, 9, and 11),
or stimulated with intact anti–
mouse IgG (lanes 3, 6, 10, and 12)
in the absence (lanes 1–3 and 7–9)
or presence (lanes 4–6 and 10–12)
of an FcgRIIB blocking reagent
(mAb 2.4G2). Cells were lysed
and soluble proteins were incu-
bated with GST (lanes 1–6) or
GST-CskSH2 (lanes 7–12). (B)
Cells were unstimulated, stimu-
lated with F(ab9)2, or stimulated
with intact anti–mouse IgG. Ly-
sates were incubated with GST (lanes 1–6) or GST-CskSH2 (lanes 7–12). GST and GST-CskSH2–bound proteins were separated on a 10% polyacryla-
mide gel, transferred to nitrocellulose, and detected by immunoblotting with an antiphosphotyrosine antibody (PY20). (B, top) A20 cells; (middle) the
FcgRIIB1-deficient cell line IIA1.6; (bottom) IIA1.6 cells in which expression of FcgRIIB1 had been restored by transfection.265 Vuica et al.
(data not shown). This binding was apparently indirect be-
cause association of p125, unlike that of p62, was not rees-
tablished after dissociation and reprecipitation (data not
shown). Association of p125 with the Csk SH2 domain is
therefore likely to be mediated by one or more additional
proteins, perhaps including GAP-A.p62. Binding of p97 to
CskSH2 was observed inconsistently. The identities of
p125 and p97 are unknown, and the significance of their
binding to Csk SH2 is unclear. Interestingly, in contrast to
previous reports (25, 36), we were not able to detect asso-
ciation of RasGAP and Csk in these experiments.
Although complexes containing Csk and GAP-A.p62
may function in the regulation of Src-related kinase activ-
ity, it has been difficult to establish such a relationship. In
addition to the changes documented here in response to
FcgRIIB1 stimulation of B cells, association of GAP-A.p62
with Csk has been documented in v-Src–transformed cells,
in resting T cells, and in T cells stimulated with anti-CD3
(25, 36). Such an association is absent in unstimulated B
cells in which Lyn activity is apparently suppressed by Csk
(37). Thus, association of p62 with Csk is not correlated
with general suppression of Src-related kinase activity. This
is underscored by the ability of intact anti-Ig antibody or
F(ab9)2 fragments to induce similar levels of Src-related ki-
nase activity in B cells (38). It has been proposed that the
association of GAP-A.p62 and Csk functions to redistribute
Csk to sites of c-Src activation (25). If so, it is possible that
at any one time, only a fraction of total cellular Src-related
kinase activity is present in such complexes and negatively
regulated by Csk. The regulation of a portion of cellular
Src-related kinase activity by recruitment into a complex
containing GAP-A.p62 and Csk might not, under this sce-
nario, be detectable by examination of bulk activity; this
may explain the failure of Csk overexpression to reduce
general Src activity in fibroblastoid cells (39). Csk could
possibly be involved in suppression of Ras activity after en-
gagement of FcgRIIB1 (40), since it has been shown that
overexpression of Csk modulates Ras activity indirectly by
suppression of Src activity (41). Alternatively, Csk may act
on substrates other than Src (42).
One common feature of proteins that associate with p62,
directly or indirectly, is their involvement in cytoskeletal
rearrangements. In addition to RasGAP (43), Csk, and Src
(44), these proteins include the g isoform of phospholipase
C (45). RasGAP can associate with p190, a molecule with
GAP activity toward the small GTP-binding proteins Rho
and Rac (46). Rho and Rac, in turn, participate in the as-
sembly of cytoskeletal structures and membrane ruffling in
response to growth factors (47, 48). RasGAP has also been
shown to regulate activity and membrane association of the g
isoform of phospholipase C (49); one of its products, dia-
cylglycerol, stimulates formation of actin nucleation sites at
plasma membranes (50) and binds the actin-severing pro-
teins gelsolin and villin (51). Tyrosine-phosphorylated GAP-
A.p62 is inferred to participate in the stabilization of Ras-
GAP interactions with the plasma membrane (52). Our
observation that association of p62 and RasGAP with Csk
SH2 is inefficiently induced by BCR engagement is consis-
tent with the observation that RasGAP does not distribute
to the membrane after BCR stimulation (53). Csk associ-
ates with p125Fak and contributes to its dephosphorylation
(54). Moreover, overexpression of Csk is associated with
reorganization of avb5 integrin and interference with cell
spreading (39). Src itself has been shown to regulate epider-
mal growth factor–dependent cytoskeletal reorganization
through phosphorylation of the p190 Rho/Rac GAP in
murine fibroblasts (55). Src-related kinases also function in
the organization of focal adhesion plaques. In cells from
Csk-deficient mice, several adhesion proteins were found
to be hyperphosphorylated through the action of Src and
Fyn (56). Although relatively little is known about cyto-
skeletal rearrangements in B cells after activation, our evi-
dence suggests that differences in the amount of p62 bound
to Csk or RasGAP could effect differential regulation of
cytoskeletal assembly after BCR or BCR-FcgRIIB1 stim-
ulation.
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